In oncology drug development, using biomarkers to select a study population more likely to benefit from a therapeutic effect is critical to increase the efficiency of a clinical trial in demonstrating ...

WESTPORT, CT / ACCESSWIRE / April 2, 2024 / CYduct Diagnostics, Inc. (OTC PINK:CYDX) ("CYduct", or the "Company"), a precision medicine-based women's health company focused on the development of ...

Add Yahoo as a preferred source to see more of our stories on Google. Enter biomarkers — “measurable signs in the body that give information about how your body and its systems are functioning,” ...

Biomarkers hold the key to more targeted and timely patient care, yet current tools for analyzing and identifying them often fall short in specificity, sensitivity, or scalability. The complexity of ...

In a recent study published in the journal Nature Medicine, researchers in Sweden and the United States assessed whether a brief self-administered digital cognitive battery, alone or combined with a ...

An expert discusses how multidisciplinary collaboration can be enhanced through shared knowledge of available drugs and biomarkers among oncologists and pathologists, standardized interpretation ...

The integration of PD-1 inhibitors into standard chemotherapy and radiotherapy regimens has revolutionized nasopharyngeal carcinoma treatment, yet only a minority of patients achieve durable responses ...